110 related articles for article (PubMed ID: 38866192)
1. GSH exhaustion via inhibition of xCT-GSH-GPX4 pathway synergistically enhanced DSF/Cu-induced cuproptosis in myelodysplastic syndromes.
Li H; Li Y; Yu Y; Ren X; Yang C; Jin W; Li K; Zhou Y; Wu C; Shen Y; Hu W; Liu Y; Yu L; Tong X; Du J; Wang Y
Free Radic Biol Med; 2024 Jun; 222():130-148. PubMed ID: 38866192
[TBL] [Abstract][Full Text] [Related]
2. Inhibiting the compensatory elevation of xCT collaborates with disulfiram/copper-induced GSH consumption for cascade ferroptosis and cuproptosis.
Zhang P; Zhou C; Ren X; Jing Q; Gao Y; Yang C; Shen Y; Zhou Y; Hu W; Jin F; Xu H; Yu L; Liu Y; Tong X; Li Y; Wang Y; Du J
Redox Biol; 2024 Feb; 69():103007. PubMed ID: 38150993
[TBL] [Abstract][Full Text] [Related]
3. Elesclomol-copper synergizes with imidazole ketone erastin by promoting cuproptosis and ferroptosis in myelodysplastic syndromes.
Gao Y; Jin F; Zhang P; Zheng C; Zheng X; Xie J; Lu Y; Tong X; Du J; Zhang J; Wang Y
Biomed Pharmacother; 2024 Jun; 175():116727. PubMed ID: 38733771
[TBL] [Abstract][Full Text] [Related]
4. A tumor microenvironment-responsive core-shell tecto dendrimer nanoplatform for magnetic resonance imaging-guided and cuproptosis-promoted chemo-chemodynamic therapy.
Ni C; Ouyang Z; Li G; Liu J; Cao X; Zheng L; Shi X; Guo R
Acta Biomater; 2023 Jul; 164():474-486. PubMed ID: 37040813
[TBL] [Abstract][Full Text] [Related]
5. Disulfiram/copper shows potent cytotoxic effects on myelodysplastic syndromes via inducing Bip-mediated apoptosis and suppressing autophagy.
Zha J; Bi S; Deng M; Chen K; Shi P; Feng L; He J; Pu X; Guo C; Zhao H; Li Z; Jiang Y; Song H; Xu B
Eur J Pharmacol; 2021 Jul; 902():174107. PubMed ID: 33865831
[TBL] [Abstract][Full Text] [Related]
6. Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram/copper-induced ferroptosis.
Ren X; Li Y; Zhou Y; Hu W; Yang C; Jing Q; Zhou C; Wang X; Hu J; Wang L; Yang J; Wang H; Xu H; Li H; Tong X; Wang Y; Du J
Redox Biol; 2021 Oct; 46():102122. PubMed ID: 34482117
[TBL] [Abstract][Full Text] [Related]
7. Glutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapy.
Chen M; Huang Z; Xia M; Ding Y; Shan T; Guan Z; Dai X; Xu X; Huang Y; Huang M; Zhao C
J Control Release; 2022 Jan; 341():351-363. PubMed ID: 34856225
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis inducers enhanced cuproptosis induced by copper ionophores in primary liver cancer.
Wang W; Lu K; Jiang X; Wei Q; Zhu L; Wang X; Jin H; Feng L
J Exp Clin Cancer Res; 2023 Jun; 42(1):142. PubMed ID: 37277863
[TBL] [Abstract][Full Text] [Related]
9. Disulfiram/Copper Induce Ferroptosis in Triple-Negative Breast Cancer Cell Line MDA-MB-231.
Chu M; An X; Fu C; Yu H; Zhang D; Li Q; Man X; Dai X; Li Z
Front Biosci (Landmark Ed); 2023 Aug; 28(8):186. PubMed ID: 37664913
[TBL] [Abstract][Full Text] [Related]
10. Abnormal Ferroptosis in Myelodysplastic Syndrome.
Lv Q; Niu H; Yue L; Liu J; Yang L; Liu C; Jiang H; Dong S; Shao Z; Xing L; Wang H
Front Oncol; 2020; 10():1656. PubMed ID: 32984038
[TBL] [Abstract][Full Text] [Related]
11. Carrier-Free Self-Assembly Nano-Sonosensitizers for Sonodynamic-Amplified Cuproptosis-Ferroptosis in Glioblastoma Therapy.
Zhu Y; Niu X; Ding C; Lin Y; Fang W; Yan L; Cheng J; Zou J; Tian Y; Huang W; Huang W; Pan Y; Wu T; Chen X; Kang D
Adv Sci (Weinh); 2024 Jun; 11(23):e2402516. PubMed ID: 38582500
[TBL] [Abstract][Full Text] [Related]
12. Low-dose hypomethylating agents cooperate with ferroptosis inducers to enhance ferroptosis by regulating the DNA methylation-mediated MAGEA6-AMPK-SLC7A11-GPX4 signaling pathway in acute myeloid leukemia.
Feng S; Yuan Y; Lin Z; Li M; Ye D; Shi L; Li D; Zhao M; Meng C; He X; Wu S; Xiong F; Ye S; Yang J; Zhuang H; Hong L; Gao S
Exp Hematol Oncol; 2024 Feb; 13(1):19. PubMed ID: 38378601
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of FXN overexpression on ferroptosis in L-Glu-induced SH-SY5Y cells.
Wang M; Xuan T; Li H; An J; Hao T; Cheng J
Acta Histochem; 2024 Jan; 126(1):152135. PubMed ID: 38266318
[TBL] [Abstract][Full Text] [Related]
14. Baicalin induces ferroptosis in osteosarcomas through a novel Nrf2/xCT/GPX4 regulatory axis.
Wen RJ; Dong X; Zhuang HW; Pang FX; Ding SC; Li N; Mai YX; Zhou ST; Wang JY; Zhang JF
Phytomedicine; 2023 Jul; 116():154881. PubMed ID: 37209607
[TBL] [Abstract][Full Text] [Related]
15. Polyphyllin I induced ferroptosis to suppress the progression of hepatocellular carcinoma through activation of the mitochondrial dysfunction via Nrf2/HO-1/GPX4 axis.
Yang R; Gao W; Wang Z; Jian H; Peng L; Yu X; Xue P; Peng W; Li K; Zeng P
Phytomedicine; 2024 Jan; 122():155135. PubMed ID: 37856990
[TBL] [Abstract][Full Text] [Related]
16. A Class of Disulfide Compounds Suppresses Ferroptosis by Stabilizing GPX4.
Liu JP; Cen SY; Xue Z; Wang TX; Gao Y; Zheng J; Zhang C; Hu J; Nie S; Xiong Y; Guan KL; Yuan HX
ACS Chem Biol; 2022 Dec; 17(12):3389-3406. PubMed ID: 36446024
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of lung adenocarcinoma by combinations of sulfasalazine (SAS) and disulfiram-copper (DSF-Cu) in cell line models and mice.
Bagherpoor AJ; Shameem M; Luo X; Seelig D; Kassie F
Carcinogenesis; 2023 Jun; 44(4):291-303. PubMed ID: 37053033
[TBL] [Abstract][Full Text] [Related]
18. Photothermally Triggered Copper Payload Release for Cuproptosis-Promoted Cancer Synergistic Therapy.
Zhou J; Yu Q; Song J; Li S; Li XL; Kang BK; Chen HY; Xu JJ
Angew Chem Int Ed Engl; 2023 Mar; 62(12):e202213922. PubMed ID: 36585379
[TBL] [Abstract][Full Text] [Related]
19. Coordination Self-Assembled AuTPyP-Cu Metal-Organic Framework Nanosheets with pH/Ultrasound Dual-Responsiveness for Synergistically Triggering Cuproptosis-Augmented Chemotherapy.
Bao J; Wang J; Chen S; Liu S; Wang Z; Zhang W; Zhao C; Sha Y; Yang X; Li Y; Zhong Y; Bai F
ACS Nano; 2024 Mar; 18(12):9100-9113. PubMed ID: 38478044
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of SLC7A11-GPX4 signal pathway is involved in aconitine-induced ferroptosis in vivo and in vitro.
Li Q; Peng F; Yan X; Chen Y; Zhou J; Wu S; Jiang W; Jin X; Liang J; Peng C; Pan X
J Ethnopharmacol; 2023 Mar; 303():116029. PubMed ID: 36503029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
